Startups
Phagenesis
https://phagenesis.comDeveloper of neurostimulation system to treat swallowing dysfunction.
Summary
Industry
Total Funding
$52.1M
- Series D (2024-04-01) $42.0M
- Series B (2011-04-01) $7.6M
- Series A (2010-01-01) $2.5M
Investors
- Northern Gritstone Series D
- British Patient Capital Series D
- EQT Life Sciences Series D
- Sectoral Asset Management Series D
- Inventages Venture Capital Investment Series B
Full Company Profile
- Access details of the company management, and other intelligence on this company by registering for Seedtable